<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    9643743
   </pmid>
   <datecreated>
    <year>
     1998
    </year>
    <month>
     07
    </month>
    <day>
     10
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1998
    </year>
    <month>
     07
    </month>
    <day>
     10
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2006
    </year>
    <month>
     11
    </month>
    <day>
     15
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0140-6736
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       351
      </volume>
      <issue>
       9111
      </issue>
      <pubdate>
       <year>
        1998
       </year>
       <month>
        Apr
       </month>
       <day>
        25
       </day>
      </pubdate>
     </journalissue>
     <title>
      Lancet
     </title>
     <isoabbreviation>
      Lancet
     </isoabbreviation>
    </journal>
    <articletitle>
     Complications of use of intrauterine devices among HIV-1-infected women.
    </articletitle>
    <pagination>
     <medlinepgn>
      1238-41
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="BACKGROUND" nlmcategory="BACKGROUND">
      A WHO expert group and the International Planned Parenthood Federation recommend against use of intrauterine devices (IUDs) in HIV-1-infected women based on theoretical concerns about pelvic infection and increased blood loss. We investigated whether the risk of complications after IUD insertion is higher in HIV-1-infected women than in non-infected women.
     </abstracttext>
     <abstracttext label="METHODS" nlmcategory="METHODS">
      649 (156 HIV-1 infected 493 non-infected) women in Nairobi, Kenya, who requested and met local eligibility criteria for insertion of an IUD were enrolled. We gathered information on IUD-related complications, including pelvic inflammatory disease, removals due to infection, pain, or bleeding, expulsions, and pregnancies at 1 and 4 months after insertion. Patients' HIV-1 status was masked from physicians.
     </abstracttext>
     <abstracttext label="FINDINGS" nlmcategory="RESULTS">
      Complications were identified in 48 of 615 women (11 [7.6%] HIV-1-infected women, 37 [7.9%] non-infected). Incident pelvic inflammatory disease (two [1.4%] HIV-1 infected, one [0.2%] non-infected) and infection-related complications (any tenderness, removal of IUD for infection or pain; ten [6.9%] HIV-1 infected, 27 [5.7%] non-infected) were also rare and similar in the two groups. Complication rates were similar by CD4 (immune) status. Multivariate analyses suggested no association between HIV-1 infection and increased risks for overall complications (odds ratio 0.8 [95% CI 0.4-1.7]) or infection-related complications (1.0 [0.5-2.3]), adjusted for marital status, study site, previous IUD use, ethnic origin, and frequency of sexual intercourse, but a slight increase cannot be ruled out.
     </abstracttext>
     <abstracttext label="INTERPRETATION" nlmcategory="CONCLUSIONS">
      Our data suggest that IUDs may be a safe contraceptive method for appropriately selected HIV-1-infected women with continuing access to medical services.
     </abstracttext>
    </abstract>
    <affiliation>
     Department of Obstetrics and Gynaecology, University of Nairobi, Kenya.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Sinei
      </lastname>
      <forename>
       S K
      </forename>
      <initials>
       SK
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Morrison
      </lastname>
      <forename>
       C S
      </forename>
      <initials>
       CS
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Sekadde-Kigondu
      </lastname>
      <forename>
       C
      </forename>
      <initials>
       C
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Allen
      </lastname>
      <forename>
       M
      </forename>
      <initials>
       M
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Kokonya
      </lastname>
      <forename>
       D
      </forename>
      <initials>
       D
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Research Support, Non-U.S. Gov't
     </publicationtype>
     <publicationtype>
      Research Support, U.S. Gov't, Non-P.H.S.
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     ENGLAND
    </country>
    <medlineta>
     Lancet
    </medlineta>
    <nlmuniqueid>
     2985213R
    </nlmuniqueid>
    <issnlinking>
     0140-6736
    </issnlinking>
   </medlinejournalinfo>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <citationsubset>
    J
   </citationsubset>
   <citationsubset>
    X
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="CommentIn">
     <refsource>
      Lancet. 1998 Apr 25;351(9111):1222-3
     </refsource>
     <pmid version="1">
      9643738
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      Lancet. 1998 Jun 27;351(9120):1963
     </refsource>
     <pmid version="1">
      9654292
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      CD4 Lymphocyte Count
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="Y">
      HIV Infections
     </descriptorname>
     <qualifiername majortopicyn="N">
      immunology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="Y">
      HIV-1
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Intrauterine Device Expulsion
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Intrauterine Devices
     </descriptorname>
     <qualifiername majortopicyn="Y">
      adverse effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Multivariate Analysis
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Pelvic Inflammatory Disease
     </descriptorname>
     <qualifiername majortopicyn="N">
      etiology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Pregnancy
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Risk Factors
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Sexually Transmitted Diseases
     </descriptorname>
     <qualifiername majortopicyn="N">
      etiology
     </qualifiername>
    </meshheading>
   </meshheadinglist>
   <otherid source="PIP">
    132844
   </otherid>
   <otherid source="POP">
    00275453
   </otherid>
   <otherabstract type="PIP">
    <abstracttext>
     Both the International Planned Parenthood Federation and the World Health Organization have warned against use of IUDs in HIV-infected women due to theoretical concerns about pelvic infection and increased blood loss.  No published studies have investigated this concern, however.  The validity of this recommendation was investigated in a comparative study of 156 HIV-1-infected and 493 non-infected women from two public family planning clinics (Kenyatta National Hospital and Riruta City Clinic) in Nairobi, Kenya, who requested and met local eligibility criteria for IUD insertion.  At 1 and 4 months after insertion, information was collected from physicians--blinded as to the patient's HIV status--on IUD-related complications such as pelvic inflammatory disease (PID), removals, expulsions, and pregnancies.  Complications were identified in 11 (7.6%) HIV-positive and 37 (7.9%) HIV-negative women.  There were only 3 incident cases of PID, 2 of which occurred in HIV-infected women.  IUD removal due to pain or infection occurred in 10 (6.9%) HIV-infected and 27 (5.7%) noninfected women.  There were no differences in overall IUD complications in HIV-1-infected women by CD4 status (severely, moderately, or mildly immunocompromised).  After adjustment for marital status, study site, previous IUD use, ethnic origin, and frequency of sexual intercourse, multivariate analysis suggested no association between HIV-1 infection and increased risks for overall IUD-related complications (odds ratio (OR), 0.8; 95% confidence interval (CI), 0.4-1.7) or infection-related complications (OR, 1.0; 95% CI, 0.5-2.3).  These findings suggest that the IUD may be a safe contraceptive method for appropriately selected HIV-infected women with continuing access to medical services.
    </abstracttext>
   </otherabstract>
   <keywordlist owner="PIP">
    <keyword majortopicyn="Y">
     Acquired Immunodeficiency Syndrome
    </keyword>
    <keyword majortopicyn="N">
     Africa
    </keyword>
    <keyword majortopicyn="N">
     Africa South Of The Sahara
    </keyword>
    <keyword majortopicyn="Y">
     Case Control Studies
    </keyword>
    <keyword majortopicyn="N">
     Contraception
    </keyword>
    <keyword majortopicyn="Y">
     Contraception Termination
    </keyword>
    <keyword majortopicyn="N">
     Contraceptive Methods--complications
    </keyword>
    <keyword majortopicyn="N">
     Developing Countries
    </keyword>
    <keyword majortopicyn="N">
     Diseases
    </keyword>
    <keyword majortopicyn="N">
     Eastern Africa
    </keyword>
    <keyword majortopicyn="N">
     English Speaking Africa
    </keyword>
    <keyword majortopicyn="N">
     Family Planning
    </keyword>
    <keyword majortopicyn="Y">
     Hiv Infections
    </keyword>
    <keyword majortopicyn="Y">
     Incidence
    </keyword>
    <keyword majortopicyn="N">
     Infections
    </keyword>
    <keyword majortopicyn="Y">
     Iud--complications
    </keyword>
    <keyword majortopicyn="N">
     Kenya
    </keyword>
    <keyword majortopicyn="N">
     Measurement
    </keyword>
    <keyword majortopicyn="Y">
     Pelvic Infections--prevention and control
    </keyword>
    <keyword majortopicyn="Y">
     Pelvic Inflammatory Disease--prevention and control
    </keyword>
    <keyword majortopicyn="N">
     Reproductive Tract Infections
    </keyword>
    <keyword majortopicyn="N">
     Research Methodology
    </keyword>
    <keyword majortopicyn="Y">
     Research Report
    </keyword>
    <keyword majortopicyn="N">
     Studies
    </keyword>
    <keyword majortopicyn="N">
     Viral Diseases
    </keyword>
   </keywordlist>
   <generalnote owner="PIP">
    TJ: LANCET.
   </generalnote>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1998
     </year>
     <month>
      6
     </month>
     <day>
      27
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1998
     </year>
     <month>
      6
     </month>
     <day>
      27
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1998
     </year>
     <month>
      6
     </month>
     <day>
      27
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     9643743
    </articleid>
    <articleid idtype="pii">
     S0140-6736(97)10319-1
    </articleid>
    <articleid idtype="doi">
     10.1016/S0140-6736(97)10319-1
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

